Browsing: pfizer

Recent research from Singapore questions whether two doses of COVID-19 vaccine are sufficient for children, exploring the necessity of booster shots amid variant concerns. Since the start of the COVID-19 pandemic, extensive research in epidemiology, clinical practice, and virology has greatly increased our understanding of the virus and its impact on human health.

Log In or Register as a healthcare professional to read the full article.

The US Food and Drug Administration (FDA) has greenlit new COVID-19 boosters for both Moderna and Pfizer, marking a proactive step in the fight against rapidly spreading infections in the country. Concurrently, Moderna and Pfizer have announced that their updated COVID-19 vaccines show a robust response against the BA.2.86 subvariant, a mutated version of the coronavirus.